ONO PHARMACEUTICAL CO.,LTD. (4528) — research page

JP · jp-cm-kg/TSE-PRIME/4528 · as of 2026-11-06

Identity and listing

The issuer is ONO PHARMACEUTICAL CO.,LTD., listed on the Prime Market under ticker 4528. The ISIN is not on the record; the LEI is 529900G26L4NG4GFJZ86. The security type is Corporate, the segment is not on the record, the sector is 3250 Pharmaceutical, and the jurisdiction is Japan (EDINET domestic filer). The issuer is listed and not halted.

The disclosure read

The record holds 12 filings in the twelve months to 2026-11-06, across 7 filing days. The filings comprise 3 ad hoc, 6 regulatory filing and 3 results. The median gap between filing days is 60.5 days. The latest filing is dated 2026-11-05, is of type regulatory filing, and falls 1 day before the record date. The Prime Market median is 29.0 days of cadence, 10 filings and 70.0 days of latency across 1557 issuers. The 3250 Pharmaceutical sector median is 49.5 days of cadence, 8.0 filings and 85.0 days of latency across 80 issuers.

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is 有限責任監査法人 ト ー マ ツ. Its location is not on the record. The auditor changes are not on the record.

Events and halts

The listing, delisting, name change, domicile change and segment move lines are not on the record, because the register has no lifecycle type map yet. The issuer is listed and not halted.

Orderability

For the client category Qualified Institutional Investors, the outcome is not determinable, because the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.

rule acm-68000/jp/suitability-principle-fiea-article-40/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's own investor-relations page names 14 research houses: BofA Securities Japan Co., Ltd., Citigroup Global Markets Japan Inc., CLSA Securities Japan Co., Ltd., Daiwa Securities Co., Ltd., Goldman Sachs Japan Co., Ltd., Jefferies Japan Limited, J.P. Morgan Securities Japan Co., Ltd., Mizuho Securities Co., Ltd., Morgan Stanley MUFG Securities Co., Ltd., Nomura Securities Co., Ltd., Pathology Associates, SBI SECURITIES Co.,Ltd., SMBC Nikko Securities Inc., and UBS AG.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

As-of depth

The vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.

Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1

https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)

10.2

https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)

10.3

https://api.gleif.org/api/v1/lei-records/529900G26L4NG4GFJZ86 (identity.lei)

10.4

https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4528 (the disclosure lines)

10.5

https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)

10.6

https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YA20 (the auditor)

10.7

https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)

10.8

https://www.ono-pharma.com/en/ir/stock/analyst (coverage)

10.9

https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4528 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"ticker":"4528","exchange":"Prime Market"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:20b920c362e6805c.